Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Therapeutic Advances in Neurological Disorders ; 14 (2021). - eISSN 1756-2864
- Schlagwort
-
COVID-19
mRNA-Impfstoff
Multiple Sklerose
Immunreaktion
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2021
- Urheber
-
Petereit, Hela-Felicitas
Tumani, Hayrettin
Zettl, Uwe K.
- DOI
-
10.18725/OPARU-46760
- URN
-
urn:nbn:de:bsz:289-oparu-46836-0
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Petereit, Hela-Felicitas
- Tumani, Hayrettin
- Zettl, Uwe K.
- Universität Ulm
Entstanden
- 2021
Ähnliche Objekte (12)
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies
Evaluation and further development of handbooks explaining different disease-modifying therapies for people with multiple sclerosis (MS)
Humoral autoimmunity in patients with breast cancer
Oncologic therapies : with 176 tables
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Exploring histone modifying complexes with a proteomic approach
Exploring histone modifying complexes with a proteomic approach
Characterization of Humoral Immune Responses to Two Subunit Malaria Vaccine Candidates in Humans
Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies
Novel therapies for graft versus host disease with a focus on cell therapies
Investigation of the humoral and cellular immune responses of chickens to Salmonella typhimurium live vaccine
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies
Evaluation and further development of handbooks explaining different disease-modifying therapies for people with multiple sclerosis (MS)
Humoral autoimmunity in patients with breast cancer
Oncologic therapies : with 176 tables
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Exploring histone modifying complexes with a proteomic approach
Exploring histone modifying complexes with a proteomic approach
Characterization of Humoral Immune Responses to Two Subunit Malaria Vaccine Candidates in Humans
Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies
Novel therapies for graft versus host disease with a focus on cell therapies
Investigation of the humoral and cellular immune responses of chickens to Salmonella typhimurium live vaccine
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies
Evaluation and further development of handbooks explaining different disease-modifying therapies for people with multiple sclerosis (MS)
Humoral autoimmunity in patients with breast cancer
Oncologic therapies : with 176 tables
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Exploring histone modifying complexes with a proteomic approach
Exploring histone modifying complexes with a proteomic approach
Characterization of Humoral Immune Responses to Two Subunit Malaria Vaccine Candidates in Humans
Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies
Novel therapies for graft versus host disease with a focus on cell therapies